The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Abstract
The immunostimulants 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and the saponin QS-21 are part of licensed or candidate vaccines. MPL and QS-21 directly affect the innate immune response to orchestrate the quality and intensity of the adaptive immune response to the vaccine antigens. The combination of immunostimulants in different adjuvant formulations forms the basis of Adjuvant Systems (AS) as a way to promote appropriate protective immune responses following vaccination. MPL and aluminum salts are present in AS04, and both MPL and QS-21 are present in AS01 and AS02, which are liposome- and emulsion-based formulations, respectively. The recent clinical performance of AS01-, AS02- and AS04-adjuvanted vaccines will be discussed in the context of the diseases being targeted. The licensing of two AS04-adjuvanted vaccines and the initiation of Phase III trials with an AS01-adjuvanted vaccine demonstrate the potential to develop new or improved human vaccines that contain MPL or MPL and QS-21.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
Masopust, D., Vezys, V., Marzo, A. L., & Lefrançois, L. (2001) · Science · doi:10.1126/science.1058867 · Cited by 1,952
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Betts, M. R. (2006) · Blood · doi:10.1182/blood-2005-12-4818 · Cited by 1,826
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,719
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Papillomaviruses in the causation of human cancers - a brief historical account
zur Hausen, H. (2009) · Virology · doi:10.1016/j.virol.2008.11.046 · Cited by 1,532
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Innate immune sensing and its roots: the story of endotoxin
Beutler, B., & Rietschel, E. T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1004 · Cited by 1,391
Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N., Apter, D. L., Kitchener, H. C., Castellsague, X., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60946-5 · Cited by 1,315
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
Tumor Antigens Recognized by T Lymphocytes
Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., & Van Pel, A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002005 · Cited by 1,221
Monocyte-Mediated Defense Against Microbial Pathogens
Serbina, N. V., Jia, T., Hohl, T. M., & Pamer, E. G. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090326 · Cited by 1,123
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Czerkinsky, C. C., Nilsson, L.-Å., Nygren, H., Ouchterlony, Ö., & Tarkowski, A. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90308-3 · Cited by 1,056
Competence and competition: the challenge of becoming a long-lived plasma cell
Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G. C., Dörner, T., & Hiepe, F. (2006) · Nature Reviews Immunology · doi:10.1038/nri1886 · Cited by 1,030
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K., Larsen, C., Zheng, N.-Y., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,025
The epidemiology of human papillomavirus infections
Baseman, J. G., & Koutsky, L. A. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.008 · Cited by 955
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review
Smith, J. S., & Robinson, N. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/343739 · Cited by 885
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Self-citationVaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
Bosch, F. X., & de Sanjose, S. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003479 · Cited by 826
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 794
Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 758
Self-citationAlonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17223-1 · Cited by 752
Malaria: progress, perils, and prospects for eradication
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H. I., Alonso, P. L., Collins, F. H., & Duffy, P. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33996 · Cited by 709
Clifford, G. M., Smith, J. S., Aguado, T., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601024 · Cited by 684
Kensil, C. R., Patel, U., Lennick, M., & Marciani, D. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.2.431 · Cited by 654
From Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 637
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
The Population Dynamics and Control of Tuberculosis
Dye, C., & Williams, B. G. (2010) · Science · doi:10.1126/science.1185449 · Cited by 604
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
Casella, C. R., & Mitchell, T. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8228-6 · Cited by 560
Bojang, K. A., Milligan, P. J., Pinder, M., Vigneron, L., Alloueche, A., Kester, K. E., Ballou, W. R., Conway, D. J., Reece, W. H., Gothard, P., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06957-4 · Cited by 528
Kester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
GIANNINI, S., HANON, E., MORIS, P., VANMECHELEN, M., MOREL, S., DESSY, F., FOURNEAU, M., COLAU, B., SUZICH, J., & LOSONKSY, G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.005 · Cited by 496
Self-citationAn estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
Looker, K. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.046128 · Cited by 493
Tuberculosis: What We Don’t Know Can, and Does, Hurt Us
Russell, D. G., Barry, C. E., & Flynn, J. L. (2010) · Science · doi:10.1126/science.1184784 · Cited by 489
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
Garçon, N., Chomez, P., & Van Mechelen, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.723 · Cited by 476
Self-citationPotocnjak, P., Yoshida, N., Nussenzweig, R. S., & Nussenzweig, V (1980) · The Journal of experimental medicine · doi:10.1084/jem.151.6.1504 · Cited by 429
Maternal and Neonatal Herpes Simplex Virus Infections
Corey, L., & Wald, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0807633 · Cited by 421
Brown, D. R., Shew, M. L., Qadadri, B., Neptune, N., Vargas, M., Tu, W., Juliar, B. E., Breen, T. E., & Fortenberry, J. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/426867 · Cited by 418
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
T cells and viral persistence: lessons from diverse infections
Klenerman, P., & Hill, A. (2005) · Nature Immunology · doi:10.1038/ni1241 · Cited by 412
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Aide, P., Sigauque, B., Milman, J., Mandomando, I., Bassat, Q., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67669-6 · Cited by 412
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Edwards, R. P., Zepp, F., Carletti, I., Dessy, F. J., Trofa, A. F., Schuind, A., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9518 · Cited by 402
Ogutu, B. R., Apollo, O. J., McKinney, D., Okoth, W., Siangla, J., Dubovsky, F., Tucker, K., Waitumbi, J. N., Diggs, C., Wittes, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004708 · Cited by 343
Lambotte, O., Ferrari, G., Moog, C., Yates, N. L., Liao, H.-X., Parks, R. J., Hicks, C. B., Owzar, K., Tomaras, G. D., Montefiori, D. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328329f97d · Cited by 342
Silvie, O., Franetich, J.-F., Charrin, S., Mueller, M. S., Siau, A., Bodescot, M., Rubinstein, E., Hannoun, L., Charoenvit, Y., Kocken, C. H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311331200 · Cited by 340
Lichterfeld, M., Kaufmann, D. E., Yu, X. G., Mui, S. K., Addo, M. M., Johnston, M. N., Cohen, D., Robbins, G. K., Pae, E., Alter, G., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041270 · Cited by 339
Gordon, D. M., McGovern, T. W., Krzych, U., Cohen, J. C., Schneider, I., LaChance, R., Heppner, D. G., Yuan, G., Hollingdale, M., Slaoui, M., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1576 · Cited by 327
Kaufmann, S. H., Hussey, G., & Lambert, P.-H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60393-5 · Cited by 299
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity
Marciani, D. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02864-2 · Cited by 290
Aponte, J. J., Aide, P., Renom, M., Mandomando, I., Bassat, Q., Sacarlal, J., Manaca, M. N., Lafuente, S., Barbosa, A., Leach, A., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61542-6 · Cited by 279
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
McElrath, M. J., & Haynes, B. F. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.011 · Cited by 270
Narum, D. L., & Thomas, A. W. (1994) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(94)90096-5 · Cited by 268
From the circumsporozoite protein to the RTS,S/AS candidate vaccine
Cohen, J., Nussenzweig, V., Vekemans, J., & Leach, A. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9677 · Cited by 247
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Abdulla, S., Oberholzer, R., Juma, O., Kubhoja, S., Machera, F., Membi, C., Omari, S., Urassa, A., Mshinda, H., Jumanne, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807773 · Cited by 239
(How) do aluminium adjuvants work?
BREWER, J. (2006) · Immunology Letters · doi:10.1016/j.imlet.2005.08.002 · Cited by 236
Organization of immunological memory by bone marrow stroma
Tokoyoda, K., Hauser, A. E., Nakayama, T., & Radbruch, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2727 · Cited by 236
Sun, P., Schwenk, R., White, K., Stoute, J. A., Cohen, J., Ballou, W. R., Voss, G., Kester, K. E., Heppner, D. G., & Krzych, U. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6961 · Cited by 232
Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses
Newman, M. J., Wu, J. Y., Gardner, B. H., Munroe, K. J., Leombruno, D., Recchia, J., Kensil, C. R., & Coughlin, R. T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2357 · Cited by 222
Chiew Tong, N. K., Beran, J., Kee, S. A., Miguel, J. L., SanNchez, C., Bayas, J. M., Vilella, A., De Juanes, J. R., Arrazola, P., Calbo-Torrecillas, F., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00689.x · Cited by 219
Vandepapelière, P., Horsmans, Y., Moris, P., Van Mechelen, M., Janssens, M., Koutsoukos, M., Van Belle, P., Clement, F., Hanon, E., Wettendorff, M., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.038 · Cited by 218
Self-citationLivingston, P. O., Adluri, S., Helling, F., Yao, T.-J., Kensilt, C. R., Newman, M. J., & Marciani, D. (1994) · Vaccine · doi:10.1016/s0264-410x(94)80052-2 · Cited by 214
Plasmodium Circumsporozoite Protein Promotes the Development of the Liver Stages of the Parasite
Singh, A. P., Buscaglia, C. A., Wang, Q., Levay, A., Nussenzweig, D. R., Walker, J. R., Winzeler, E. A., Fujii, H., Fontoura, B. M. A., & Nussenzweig, V. (2007) · Cell · doi:10.1016/j.cell.2007.09.013 · Cited by 213
van Dissel, J. T., Arend, S. M., Prins, C., Bang, P., Tingskov, P. N., Lingnau, K., Nouta, J., Klein, M. R., Rosenkrands, I., Ottenhoff, T. H. M., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.094 · Cited by 203
Black, M., Trent, A., Tirrell, M., & Olive, C. (2010) · Expert Review of Vaccines · doi:10.1586/erv.09.160 · Cited by 203
The Cycle of Human Herpes Simplex Virus Infection: Virus Transport and Immune Control
Cunningham, A. L., Diefenbach, R. J., Miranda‐Saksena, M., Bosnjak, L., Kim, M., Jones, C., & Douglas, M. W. (2006) · The Journal of Infectious Diseases · doi:10.1086/505359 · Cited by 203
Descamps, D., Hardt, K., Spiessens, B., Izurieta, P., Verstraeten, T., Breuer, T., & Dubin, G. (2009) · Human Vaccines · doi:10.4161/hv.5.5.7211 · Cited by 199
Eddahri, F., Denanglaire, S., Bureau, F., Spolski, R., Leonard, W. J., Leo, O., & Andris, F. (2009) · Blood · doi:10.1182/blood-2008-04-154682 · Cited by 196
Soltysik, S., Wu, J.-Y., Recchia, J., Wheeler, D. A., Newman, M. J., Coughlin, R. T., & Kensil, C. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00077-e · Cited by 188
Differentiation of memory B and T cells
Kalia, V., Sarkar, S., Gourley, T. S., Rouse, B. T., & Ahmed, R. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.020 · Cited by 186
Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients
Atanackovic, D., Altorki, N. K., Stockert, E., Williamson, B., Jungbluth, A. A., Ritter, E., Santiago, D., Ferrara, C. A., Matsuo, M., Selvakumar, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3289 · Cited by 184
Vandepapelière, P., Lau, G. K. K., Leroux-Roels, G., Horsmans, Y., Gane, E., Tawandee, T., Merican, M. I. B., Win, K. M., Trepo, C., Cooksley, G., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.072 · Cited by 180
Potter, S. J., Lacabaratz, C., Lambotte, O., Perez-Patrigeon, S., Vingert, B., Sinet, M., Colle, J.-H., Urrutia, A., Scott-Algara, D., Boufassa, F., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01401-07 · Cited by 175
Immunology and the elusive AIDS vaccine
Virgin, H. W., & Walker, B. D. (2010) · Nature · doi:10.1038/nature08898 · Cited by 171
De Carvalho, N., Teixeira, J., Roteli-Martins, C. M., Naud, P., De Borba, P., Zahaf, T., Sanchez, N., & Schuind, A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.007 · Cited by 169
Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
Reed, S. G., Coler, R. N., Dalemans, W., Tan, E. V., DeLa Cruz, E. C., Basaraba, R. J., Orme, I. M., Skeiky, Y. A. W., Alderson, M. R., Cowgill, K. D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712077106 · Cited by 167
Kannanganat, S., Kapogiannis, B. G., Ibegbu, C., Chennareddi, L., Goepfert, P., Robinson, H. L., Lennox, J., & Amara, R. R. (2007) · Journal of Virology · doi:10.1128/jvi.01261-07 · Cited by 159
Atanackovic, D., Altorki, N. K., Cao, Y., Ritter, E., Ferrara, C. A., Ritter, G., Hoffman, E. W., Bokemeyer, C., Old, L. J., & Gnjatic, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707140104 · Cited by 158
Efficacy of Murine Malaria Sporozoite Vaccines: Implications for Human Vaccine Development
Egan, J. E., Weber, J. L., Ballou, W. R., Hollingdale, M. R., Majarian, W. R., Gordon, D. M., Maloy, W. L., Hoffman, S. L., Wirtz, R. A., Schneider, I., et al. (1987) · Science · doi:10.1126/science.3551073 · Cited by 155
Verstraeten, T., Descamps, D., David, M., Zahaf, T., Hardt, K., Izurieta, P., Dubin, G. O., & Breuer, T. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.049 · Cited by 155
Petäjä, T., Keränen, H., Karppa, T., Kawa, A., Lantela, S., Siitari‐Mattila, M., Levänen, H., Tocklin, T., Godeaux, O., Lehtinen, M., et al. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.10.002 · Cited by 153
QS-21: a water-soluble triterpene glycoside adjuvant
Kensil, C. R., & Kammer, R. B. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.9.1475 · Cited by 152
David, M., Herck, K. V., Hardt, K., Tibaldi, F. S., Dubin, G. O., Descamps, D., & Damme, P. V. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.01.011 · Cited by 152
Schwarz, T. F., Spaczyński, M., Schneider, A., Wysocki, J., Gałaj, A., Perona, P., Poncelet, S. M., Zahaf, T., Hardt, K., Descamps, D., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.10.088 · Cited by 152
Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs
Rhodes, J., Chen, H., Hall, S. R., Beesley, J. E., Jenkins, D. C., Collins, P. M., & Zheng, B. Q. (1995) · Nature · doi:10.1038/377071a0 · Cited by 151
Vansteenkiste, J., Zielinski, M., Linder, A., Dahabre, J., Esteban, E., Malinowski, W., Jassem, J., Passlick, B., Lehmann, F. F., & Brichard, V. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.7554 · Cited by 151
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Polhemus, M. E., Remich, S. A., Ogutu, B. R., Waitumbi, J. N., Otieno, L., Apollo, S., Cummings, J. F., Kester, K. E., Ockenhouse, C. F., Stewart, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006465 · Cited by 145
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
The ABC of clinical and experimental adjuvants—A brief overview
Brunner, R., Jensen‐Jarolim, E., & Pali‐Schöll, I. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.10.005 · Cited by 140
Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
Sacarlal, J., Aíde, P., Aponte, J. J., Renom, M., Leach, A. J., Mandomando, I., Lievens, M., Bassat, Q., Lafuente, S., Macete, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600119 · Cited by 133
Deschuyteneer, M., Elouahabi, A., Plainchamp, D., et al. (2010) · Human Vaccines · doi:10.4161/hv.6.5.11023 · Cited by 132
Vansteenkiste, J., Lara, P. N., Chevalier, T. L., Breton, J.-L., Bonomi, P., Sandler, A. B., Socinski, M. A., Delbaldo, C., McHenry, B. M., Lebwohl, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7097 · Cited by 130
Kester, K. E., Cummings, J. F., Ockenhouse, C. F., Nielsen, R. K., Hall, B. T., Gordon, D. M., Schwenk, R., Krzych, U., Holland, C. A., Richmond, G., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.048 · Cited by 128
Garçon, N., Heppner, D. G., & Cohen, J. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.231 · Cited by 118
Self-citationSkeiky, Y. A. W., Lodes, M. J., Guderian, J. A., Mohamath, R., Bement, T., Alderson, M. R., & Reed, S. G. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3998-4007.1999 · Cited by 118
Schwarz, T. F., & Léo, O. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.05.036 · Cited by 116
QS-21 structure/function studies: effect of acylation on adjuvant activity
Liu, G., Anderson, C., Scaltreto, H., Barbon, J., & Kensil, C. R. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00209-8 · Cited by 114
Stewart, V. A., McGrath, S. M., Dubois, P. M., Pau, M. G., Mettens, P., Shott, J. P., Cobb, M., Burge, J. R., LARSON, D. L., Ware, L. A., et al. (2007) · Infection and Immunity · doi:10.1128/iai.01879-06 · Cited by 103
Guinovart, C., Aponte, J. J., Sacarlal, J., Aíde, P., Leach, A. J., Bassat, Q., Macete, E., Dobaño, C., Lievens, M., Loucq, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005165 · Cited by 101
Polhemus, M. E., Magill, A. J., Cummings, J. F., Kester, K. E., Ockenhouse, C. F., Lanar, D. E., Dutta, S., Barbosa, A., Soisson, L. A., Diggs, C. L., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.012 · Cited by 98
Tuberculosis vaccines — an update
Andersen, P. L. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1703 · Cited by 96
Lanzavecchia, A., & Sallusto, F. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.019 · Cited by 94
Goepfert, P., Tomaras, G. D., Horton, H., Montefiori, D. C., Ferrari, G., Deers, M., Voss, G., Koutsoukos, M., Pedneault, L., Vandepapelière, P., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.07.050 · Cited by 94
Stewart, V. A., McGrath, S. M., Walsh, D. S., Davis, S. L., Hess, A. S., Ware, L. A., Kester, K. E., Cummings, J. F., Burge, J. R., Voss, G., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.033 · Cited by 94
Self-citationRoestenberg, M., Remarque, E. J., de Jonge, E., Hermsen, R. C., Blythman, H., Leroy, O. Y., Imoukhuede, E. B., Jepsen, S. V., Ofori‐Anyinam, O., Faber, B. W., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003960 · Cited by 92
Cummings, J. F., Spring, M., Schwenk, R., Ockenhouse, C. F., Kester, K. E., Polhemus, M. E., Walsh, D. S., Yoon, I., Prosperi, C., Juompan, L. Y., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.046 · Cited by 90
Kemp, T. J., García‐Piñeres, A., Falk, R. T., Poncelet, S. M., Dessy, F. J., Giannini, S. L., Rodríguez, A. C., Porras, C., Herrero, R., Hildesheim, A., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.074 · Cited by 90
Lell, B., Agnandji, S., von Glasenapp, I., Haertle, S., Oyakhiromen, S., Issifou, S., Vekemans, J., Leach, A., Lievens, M., Dubois, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007611 · Cited by 89
Vantomme, V., Dantinne, C., Amrani, N., Permanne, P., Gheysen, D., Bruck, C., Stoter, G., Britten, C. M., Keilholz, U., Lamers, C. H. J., et al. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200403000-00006 · Cited by 87
Rickman, L., Rickman, L., Wistar, R., Hoffman, S. L., Gordon, D. M., Krzych, U., Egan, J. E., Chulay, J. D., Gross, M. S., & Hollingdale, M. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)92659-p · Cited by 86
Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
Schwarz, T. F. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0079-5 · Cited by 83
Höfer, T., Muehlinghaus, G., Moser, K., Yoshida, T., Mei, H. E., Hebel, K., Hauser, A. E., Hoyer, B. F., Luger, E., Dörner, T., et al. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00380.x · Cited by 83
Mettens, P., Dubois, P. M., Demoitié, M., Bayat, B., Donner, M.-N., Bourguignon, P., Stewart, V. A., Heppner, D. G., Garçon, N., & Cohen, J. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.018 · Cited by 81
Self-citationPlasmodium falciparum malaria vaccines in development
Vekemans, J., & Ballou, W. R. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.2.223 · Cited by 81
Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins
Marciani, D. J., Pathak, A. K., Reynolds, R. C., Seitz, L. E., & May, R. D. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00016-9 · Cited by 78
Leroux‐Roels, I., Koutsoukos, M., Clément, F., Steyaert, S., Janssens, M., Bourguignon, P., Cohen, K. W., Altfeld, M. A., Vandepapelière, P., Pedneault, L., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.035 · Cited by 78
Recent findings in immunology give tuberculosis vaccines a new boost
Kaufmann, S. H. E. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.09.012 · Cited by 77
Hoffman, S. L., Edelman, R., Bryan, J. P., Schneider, I., Davis, J., Sedegah, M., Gordon, D. M., Church, P., Gross, M., Silverman, C., et al. (1994) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.603 · Cited by 71
Braeckel, E. V., Bourguignon, P., Koutsoukos, M., Clément, F., Janssens, M., Carletti, I., Collard, A., Demoitié, M., Voss, G., Leroux-Roels, G. G., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq160 · Cited by 63
Brichard, V. G., & Lejeune, D. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.951 · Cited by 62
Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?
Montefiori, D. C., & Mascola, J. R. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832f4a4d · Cited by 61
New concepts in herpes simplex virus vaccine development: notes from the battlefield
Dasgupta, G., Chentoufi, A. A., Nesburn, A. B., Wechsler, S. L., & BenMohamed, L. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.60 · Cited by 61
Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine
Kurtis, J. D., Hollingdale, M. R., Luty, A. J. F., Lanar, D. E., Krzych, U., & Duffy, P. E. (2001) · Trends in Parasitology · doi:10.1016/s0169-4758(00)01862-7 · Cited by 60
Vogel, F. R. (1998) · PubMed · Cited by 60
Rivera-Medina, D. M., Valencia, A., de Velasquez, A., Huang, L., Prymula, R., García-Sicilia, J., Rombo, L., David, M. P., Descamps, D., Hardt, K., et al. (2010) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2010.02.006 · Cited by 59
Waitumbi, J. N., Anyona, S. B., W., H., Kifude, C., Polhemus, M. E., Walsh, D. S., Ockenhouse, C. F., Heppner, D. G., Leach, A. J., Lievens, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007849 · Cited by 58
The major merozoite surface protein as a malaria vaccine target
Diggs, C. L., Ballou, W. R., & Miller, L. H. (1993) · Parasitology Today · doi:10.1016/0169-4758(93)90130-8 · Cited by 57
Bhatla, N., Suri, V., Basu, P. S., Shastri, S. S., Datta, S. K., Bi, D., Descamps, D., Bock, H. L., & the Indian HPV Vaccine Study Group (2010) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2009.01167.x · Cited by 55
Development of the RTS,S/AS malaria candidate vaccine
Vekemans, J., Leach, A. J., & Cohen, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.013 · Cited by 52
Schwarz, T. F., Kocken, M., Petäjä, T., Einstein, M. H., Spaczyński, M., Louwers, J. A., Pedersen, C., Levin, M. J., Zahaf, T., Poncelet, S. M., et al. (2010) · Human Vaccines · doi:10.4161/hv.6.12.13399 · Cited by 51
CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses
Barouch, D. H., & Letvin, N. L. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00244-2 · Cited by 50
Immunological Foundations to the Quest for New Vaccine Adjuvants
Burdin, N., Guy, B., & Moingeon, P. E. (2004) · BioDrugs · doi:10.2165/00063030-200418020-00002 · Cited by 49
Barbosa, A., Naniche, D., Aponte, J. J., Manaca, M. N., Mandomando, I., Aíde, P., Sacarlal, J., Renom, M., Lafuente, S., Ballou, W. R., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00442-09 · Cited by 44
Konno, R., Tamura, S., Dobbelaere, K., & Yoshikawa, H. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181da2128 · Cited by 44
Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
Konno, R., Tamura, S., Dobbelaere, K., & Yoshikawa, H. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181d373a5 · Cited by 43
Pichyangkul, S., Kum-Arb, U., Yongvanitchit, K., Limsalakpetch, A., Gettayacamin, M., Lanar, D. E., Ware, L. A., Stewart, V. A., Heppner, D. G., Mettens, P., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00977-07 · Cited by 41
Immunization With a Recombinant MAGE-A3 Protein After High-dose Therapy for Myeloma
Szmania, S. M., Gnjatic, S., Tricot, G. J. K., Stone, K., Zhan, F., Moreno, A., Thuro, B. A., Melenhorst, J. J., Barrett, J. A., Shaughnessy, J. D., et al. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318158fcff · Cited by 40
García-Sicilia, J., Schwarz, T. F., Carmona, A., Peters, K., Malkin, J., Tran, P. M., Behre, U., Iturbe, E. B., Catteau, G., Thomas, F., et al. (2010) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2009.11.205 · Cited by 39
Pichyangkul, S., Tongtawe, P., Kum-Arb, U., Yongvanitchit, K., Gettayacamin, M., Hollingdale, M. R., Limsalakpetch, A., Stewart, V. A., Lanar, D. E., Dutta, S., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.022 · Cited by 37
Kim, Y., Kim, K.-T., Kim, J., Cha, S.-D., Kim, J., Bae, D., Nam, J.-H., Ahn, W. S., & Choi, H. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.8.1197 · Cited by 37
Cellular effector mechanisms againstPlasmodiumliver stages
Frevert, U., & Nardin, E. H. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01211.x · Cited by 36
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial
Sacarlal, J., Aponte, J. J., Aíde, P., Mandomando, I., Bassat, Q., Guinovart, C., Leach, A. J., Milman, J., Macete, E., Espasa, M., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.11.003 · Cited by 35
Human immunodeficiency virus‐1 vaccine design: where do we go now?
Wijesundara, D. K., Jackson, R. J., Ramshaw, I. A., & Ranasinghe, C. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.118 · Cited by 35
Konno, R., Dobbelaere, K., Godeaux, O., Tamura, S., & Yoshikawa, H. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a23c0e · Cited by 32
Ngan, H., Cheung, A., Tam, K. F., Chan, K. K. L., Tang, H., Bi, D., Descamps, D., & Bock, H. L. (2010) · PubMed · Cited by 30
Immunotherapy in the landscape of new targeted treatments for non‐small cell lung cancer
Gerard, C. M., & Debruyne, C. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.09.001 · Cited by 27
Audran, R., Lurati, F., Genton, B., Blythman, H., Ofori‐Anyinam, O., Reymond, C., Corradin, G., & Spertini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007304 · Cited by 25
Monophosphoryl Lipid A and Synthetic Lipid A Mimetics As TLR4-Based Adjuvants and Immunomodulators
Baldridge, J. R., Myers, K. R., Johnson, D. A., Persing, D. H., Cluff, C. W., & Hershberg, R. M. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-970-7_12 · Cited by 15
Mapping the future of HIV vaccines
Nabel, G. J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1713 · Cited by 11
Cited by
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501184 · Cited by 1,454
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Del Giudice, G., Rappuoli, R., & Didierlaurent, A. M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.001 · Cited by 610
Moses, T., Papadopoulou, K. K., & Osbourn, A. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.953628 · Cited by 557
Liposomes as vaccine delivery systems: a review of the recent advances
Schwendener, R. A. (2014) · Therapeutic Advances in Vaccines · doi:10.1177/2051013614541440 · Cited by 525
Metadata
- Authors
- Garçon, N., & Van Mechelen, M.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2011-04
- Volume
- 10
- Issue
- 4
- Pages
- 471-486
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2149883005
- Cited by
- 314
- References
- 164
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.